These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 1678778)
1. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein. Fenouillet E; Gluckman JC J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778 [TBL] [Abstract][Full Text] [Related]
2. Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. Benjouad A; Gluckman JC; Rochat H; Montagnier L; Bahraoui E J Virol; 1992 Apr; 66(4):2473-83. PubMed ID: 1347797 [TBL] [Abstract][Full Text] [Related]
3. Recombinant HIV envelope expressed in an alpha-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functional. Fenouillet E; Papandréou MJ; Jones IM Virology; 1997 Apr; 231(1):89-95. PubMed ID: 9143306 [TBL] [Abstract][Full Text] [Related]
4. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Fenouillet E; Miquelis R; Drillien R Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025 [TBL] [Abstract][Full Text] [Related]
5. Processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1 in the presence of trimming glucosidase inhibitor deoxynojirimycin. Pal R; Kalyanaraman VS; Hoke GM; Sarngadharan MG Intervirology; 1989; 30(1):27-35. PubMed ID: 2542177 [TBL] [Abstract][Full Text] [Related]
6. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain. Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218 [TBL] [Abstract][Full Text] [Related]
7. Functions of HIV envelope glycans. Fenouillet E; Gluckman JC; Jones IM Trends Biochem Sci; 1994 Feb; 19(2):65-70. PubMed ID: 8160267 [TBL] [Abstract][Full Text] [Related]
8. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity. Sjölander S; Bolmstedt A; Akerblom L; Horal P; Olofsson S; Morein B; Sjölander A Virology; 1996 Jan; 215(2):124-33. PubMed ID: 8560759 [TBL] [Abstract][Full Text] [Related]
9. Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain. Papandreou MJ; Fenouillet E Virology; 1998 Feb; 241(1):163-7. PubMed ID: 9454727 [TBL] [Abstract][Full Text] [Related]
10. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1. Keay S; Tacket CO; Murphy JR; Handwerger BS AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1091-8. PubMed ID: 1503823 [TBL] [Abstract][Full Text] [Related]
11. The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step. Papandréou MJ; Barbouche R; Guieu R; Kieny MP; Fenouillet E Mol Pharmacol; 2002 Jan; 61(1):186-93. PubMed ID: 11752220 [TBL] [Abstract][Full Text] [Related]
12. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Gruters RA; Neefjes JJ; Tersmette M; de Goede RE; Tulp A; Huisman HG; Miedema F; Ploegh HL Nature; 1987 Nov 5-11; 330(6143):74-7. PubMed ID: 2959866 [TBL] [Abstract][Full Text] [Related]
13. Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Network. Gorse GJ; Frey SE; Newman FK; Belshe RB J Clin Microbiol; 1992 Oct; 30(10):2606-12. PubMed ID: 1400960 [TBL] [Abstract][Full Text] [Related]
14. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. Pal R; Hoke GM; Sarngadharan MG Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446 [TBL] [Abstract][Full Text] [Related]
15. Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network. Gorse GJ; Frey SE; Patel G; Newman FK; Belshe RB Vaccine; 1994 Aug; 12(10):912-8. PubMed ID: 7975833 [TBL] [Abstract][Full Text] [Related]
16. Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. Fenouillet E; Gluckman JC; Bahraoui E J Virol; 1990 Jun; 64(6):2841-8. PubMed ID: 2335819 [TBL] [Abstract][Full Text] [Related]
17. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells. Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050 [TBL] [Abstract][Full Text] [Related]
18. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. Abacioglu YH; Fouts TR; Laman JD; Claassen E; Pincus SH; Moore JP; Roby CA; Kamin-Lewis R; Lewis GK AIDS Res Hum Retroviruses; 1994 Apr; 10(4):371-81. PubMed ID: 8068416 [TBL] [Abstract][Full Text] [Related]
19. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells. Koka P; He K; Camerini D; Tran T; Yashar SS; Merrill JE J Neuroimmunol; 1995 Mar; 57(1-2):179-91. PubMed ID: 7706435 [TBL] [Abstract][Full Text] [Related]
20. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. Fenouillet E; Jones IM J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]